|
Nominations Being Accepted for the DCP Early Career Scientist
Opportunity
The NCI Division of Cancer Prevention Early Career Scientist Opportunity highlights early career scientists who are advancing research within the areas supported by DCP, including:
- Cancer Early Detection Biomarker Development and Screening
- Intervention Development for Cancer Prevention
- Precision Cancer Prevention
- Symptom Science and Management
Selected nominees are invited to present their research in the Early Career Scientist Spotlight Seminar Series and will have the opportunity to meet with staff involved in cancer prevention research across DCP and NCI. The deadline for nominations is July 31, 2025.
Learn more.
|
MCD Workshop Proceedings Available: Opportunities and Challenges for the Development and Adoption of Multicancer Detection Tests
Several NCI staff, including DCP Director Philip Castle, Ph.D., M.P.H., Christos Patriotis, Ph.D., and Wendy Rubinstein, M.D., Ph.D., participated in the October 2024 workshop held by the National Academies National Cancer Policy Forum. The workshop explored the current scientific understanding and clinical use of multicancer detection tests and implications for cancer care and outcomes.
Download the proceedings.
|
Metformin and Intensive Lifestyle Intervention Effects on Cancer Incidence
|
DCP’s Brandy Heckman-Stoddard, Ph.D., M.P.H., and collaborators across NIH and other institutions, recently published an evaluation showing that interventions involving weight loss or the drug metformin did not reduce cancer risk among participants in the long-term Diabetes Prevention Program Outcome Study (DPPOS).
Read more.
|
|
 |
New Cancer Treatment Tolerability Consortium Video
 |
|
The Cancer Treatment Tolerability Consortium released a new video for researchers and clinicians. This video introduces the Breast Cancer Symptom Explorer, a powerful research-facing tool for visualizing adverse events (AEs) and quality-of-life (QOL) data in breast cancer clinical trials. |
|
|
Building Bridges in Cancer Symptom Science: Diet and Nutrition for Managing Cancer Symptoms
Tuesday May 27
12:00 – 1:00 p.m. ET
Advance registration required
In this second webinar in the 2025 Building Bridges in Cancer Symptom Science series, Dr. Melinda Irwin from Yale School of Public Health, and Dr. Luke Peppone from the University of Rochester Medical Center will discuss research on diet and nutrition and cancer symptom science. Dr. Irwin will discuss lifestyle nutrition intervention studies and Dr. Peppone will discuss research on nutritional supplementation for managing cancer symptoms.
Learn more.
|
|
|
Apply to Participate in the NCI S³ Innovation Lab
The Synthetic and Systems Approaches to Interrogate Spatiotemporal Processes in Cancer Initiation (S3) Innovation lab is a five-day virtual event that will bring together interdisciplinary researchers to form collaborative teams and develop actionable pilot project proposals to deepen our understanding of cancer initiation. The Innovation Lab is sponsored by NCI’s Creative Collaborations Foundry.
Application deadline is May 27, 2025.
Learn more and apply.
|
|
|
The Cancer Prevention Research Conference 2025
Tuesday, June 25 – Friday, June 27
London, UK
Join researchers from around the world at the Cancer Prevention Research Conference to discuss big questions facing cancer prevention with the brightest minds in prevention research. Over three days, participants will engage with the latest science and perspectives from leaders across the research continuum and make connections that inspire novel ideas and accelerate cancer prevention research.
Learn more and register.
|
NCI PREVENT Cancer Program – Research Support Opportunity in
Cancer Prevention & Interception
2025 Deadlines: Monday, June 2 and November 3, 2025.
For more information on Program support, types of
supported projects, and the application visit the
PREVENT web page.
|
NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Virtual Annual Summit
Thursday, July 24, 2025
8:45 a.m. – 4:45 p.m. ET
Registration Deadline: May 16, 2025.
A draft agenda is available on the registration page.
For more information on CAP-IT visit NCICAP-IT.org or email CAP-IT@nih.gov.
Register now.
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
|
Through this Notice of Funding Opportunity (NOFO), NCI intends to support the discovery and development of novel natural products that are safe, non-toxic, and efficacious for cancer interception and prevention.
RFA-CA-25-013
Expires: June 14, 2025
|
|
 |
In case you missed it:
Read more DCP Updates.
Follow DCP's LinkedIn page.
See all Meetings and Events on the DCP Website.
Do you forward DCP Updates to others?
Encourage them to subscribe.
|
|
|
|
